产品中心 抗体 其他一抗

所有图片(1/1)

CD105 Mouse mAb (S-837-10)

Endoglin,ENG,END

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0531
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 分子别名

    Endoglin, ENG, END
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane
  • Accession

    P17813
  • 克隆号

    S-837-10
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG2b,k
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度
    FCM 1:2000
背景介绍
  • Endoglin (ENG) is a type I membrane glycoprotein located on cell surfaces and is part of the TGF beta receptor complex. It is also commonly referred to as CD105, END, FLJ41744, HHT1, ORW and ORW1. Endoglin has been found to be an auxiliary receptor for the TGF-beta receptor complex. It thus is involved in modulating a response to the binding of TGF-beta1, TGF-beta3, activin-A, BMP-2, BMP-7 and BMP-9. Beside TGF-beta signaling endoglin may have other functions. It has been postulated that endoglin is involved in the cytoskeletal organization affecting cell morphology and migration. Endoglin has a role in the development of the cardiovascular system and in vascular remodeling. Its expression is regulated during heart development. In humans endoglin may be involved in the autosomal dominant disorder known as hereditary hemorrhagic telangiectasia (HHT) type 1.

  • 流式分析

    • Flow cytometric analysis of Jurkat (Human T cell leukemia T lymphocyte, left) / HeLa (Human cervix adenocarcinoma epithelial cell, right) cells labelling CD105 antibody at 1/2000 dilution (0.1 μg)/ (Red) compared with a Mouse monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody.
      Negative control: Jurkat

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)